StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bernstein SocGen Group Starts Incyte (INCY) at Market Perform
May 21, 2026 4:24 PM
(Updated - May 21, 2026 4:39 PM EDT)
Bernstein SocGen Group analyst Jeffrey Walch initiates coverage on Incyte (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
New Coverage
Next Articles
Form 4 INCYTE CORP For: May 19 Filed by: Clancy Paul J
May 21, 2026 4:02 PM
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
May 21, 2026 6:38 AM
Form 4/A INCYTE CORP For: May 06 Filed by: Stein Steven H
May 20, 2026 4:02 PM
Form 4/A INCYTE CORP For: May 06 Filed by: CAGNONI PABLO J
May 20, 2026 4:02 PM
Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
May 20, 2026 8:00 AM
JPMorgan Reinstates Incyte (INCY) at Neutral
May 20, 2026 4:30 AM
Form 144 INCYTE CORP Filed by: Clancy Paul J
May 19, 2026 4:21 PM
Incyte partners with Edison Scientific to deploy AI platform for drug research
May 19, 2026 8:00 AM
Incyte and Edison Scientific Announce Strategic Collaboration to Employ the Kosmos AI Platform for Research and Development
May 19, 2026 8:00 AM
